Ερευνητικο εργο- Δημοσιευσεις σε εγκριτα διεθνη επιστημονικα περιοδικα
Flessa CM, Zampeli E, Evangelopoulos ME, Natsis V, Bodewes ILA, Huijser E, Versnel MA, Moutsopoulos HM, Mavragani CP. Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome. Front Immunol. 2022;13:836824.
Papagoras C, Fragoulis GE, Zioga N, Simopoulou T, Deftereou K, Kalavri E, Zampeli E, et al. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases. Ann Rheum Dis. 2022;81:1013-1016.
Pezoulas VC, Goules A, Kalatzis F, Chatzis L, Kourou KD, Venetsanopoulou A, Exarchos TP, Gandolfo S, Votis K, Zampeli E, et aI. Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts. Comput Struct Biotechnol J. 2022;20:471-484.
Zampeli E, Zervas E. Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab. Mediterr J Rheumatol. 2021;32:376-377.
Zampeli E, Venetsanopoulou AI, Christaki S, Argyropoulou OD, Boki KA, Manoussakis MN, Skopouli FN, Tzioufas AG, Moutsopoulos HM. Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature. Clin Exp Rheumatol. 2021;Epub ahead of print.
Papagoras C, Fragoulis GE, Zioga N, Simopoulou T, Deftereou K, Kalavri E, Zampeli E, et al. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases. Ann Rheum Dis. 2021:annrheumdis-2021-221539.
Zampeli E, Anagnostopoulos C, Moutsopoulos HM. An unusual presentation of giant cell arteritis in a middle-aged woman. Clin Exp Rheumatol. 2021;39 Suppl 129:187-188.
Cinoku II, Zampeli E, Moutsopoulos HM. Medical education in Greece: Necessary reforms need to be re-considered. Med Teach. 2021;43:287-292.
Goules AV, Argyropoulou OD, Pezoulas VC, Chatzis L, Critselis E, Gandolfo S, Ferro F, Binutti M, Donati V, Zandonella Callegher S, Venetsanopoulou A, Zampeli E, et al. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development. Front Immunol. 2020;11:594096.
Argyropoulou OD, Pezoulas V, Chatzis L, Critselis E, Gandolfo S, Ferro F, Quartuccio L, Donati V, Treppo E, Bassoli CR, Venetsanopoulou A, Zampeli E, et al. Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. Semin Arthritis Rheum. 2020;50:846-853.
Chatzis L, Pezoulas VC, Ferro F, Gandolfo S, Donati V, Binutti M, Callegher SZ, Venetsanopoulou A, Zampeli E, et al. Sjögren's Syndrome: The Clinical Spectrum of Male Patients. J Clin Med. 2020;9:2620.
Zampeli E Zervas E. Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab. Mediterr J Rheumatol. 2022;20:471-484.
Zampeli E, Marinos L, Karakatsanis SJ. Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome. Clin Med (Lond). 2020;20:229- 230.
Zampeli E, Mavrommati M, Moutsopoulos HM, Skopouli FN. Anti-Ro52 and/or anti- Ro60 immune reactivity: autoantibody and disease associations. Clin Exp Rheumatol. 2020 Feb 18. [Epub ahead of print]
Zampeli E, Moutsopoulos HM. Facial papular lesions in a woman with ganulomatosis with polyangiitis. Arthritis Rheumatol 2020;72:864.
Cinoku I, Zampeli E, Mavragani CP, Skopouli FN, Moutsopoulos HM. Myositis autoantibodies: Clinical significance of higher cut- offs using the Euroimmun Research Line Blot. Arthritis Rheumatol 2020;72:1042-1044.
Evangelatos G, Fragoulis GE, Zampeli E, Kechagia M, Iliopoulos A. Zoledronic acid is effective and safe in migratory osteoporosis. Rheumatology (Oxford). 2020;59:439-440
Pezoulas VC, Kourou KD, Kalatzis F, Exarchos TP, Venetsanopoulou AI, Zampeli E, Gandolfo S, Skopouli FN, De Vita S, Tzioufas AG, Fotiadis DI. Enhancing medical data quality through data curation: a case study in primary Sjögren'ssyndrome. Clin Exp Rheumatol 2019;Suppl 118:90-96.
Zampeli E, Pantelidaki A, Moutsopoulos HM. Evolution of one systemic rheumatic disease into another: scleroderma evolving to eosinophilic fasciitis with myositis. Clin Exp Rheumatol 2019;Suppl 119:149-150.
Zampeli E, Moutsopoulos HM. Lesson of the month 2: Fever, arthralgias and hyperkeratotic, scaling and fissuring eruptions of the hands. Clin Med (Lond). 2019;19:255-256.
Zampeli E, Moutsopoulos HM. Dapsone: an old drug effective for subacute cutaneous lupus erythematosus. Rheumatology (Oxford). 2019;58:920-921
Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies. Clin Rheumatol. 2019;38:125-132.
Pezoulas VC, Kourou KD, Kalatzis F, Exarchos TP, Venetsanopoulou A, Zampeli E, Gandolfo S, Skopouli F, De Vita S, Tzioufas AG, Fotiadis DI. Medical data quality assessment: On the development of an automated framework for medical data curation.Comput Biol Med. 2019;107:270-283.
Argyropoulou OD, Zampeli E, Sipsas NV, Tzioufas AG, Moutsopoulos HM. Severe cutaneous hand infection: Mycobacterium marinum in an immunosuppressed patient.Clin Exp Rheumatol. 2018;36:1117.
Zampeli E, Moutsopoulos HM. Keratoderma Blenorrhagica. Arthritis Rheumatol. 2018;70:2056.
Zampeli E, Kalogirou EM, Piperi E, Mavragani CP, Moutsopoulos HM. Tongue Atrophy in Sjögren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands? J Rheumatol. 2018;45:1565-1571.
Zampeli E, Skopouli FN, Moutsopoulos HM. Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome. J Rheumatol. 2018;45:877-878.
Zampeli E, Moutsopoulos HM. Relapsing polychondritis: a diagnosis not to be missed. Rheumatology (Oxford). 2018;57:1768.
Karagianni P, Zampeli E, Moutsopoulos HM. Evolution from one autoimmune disorder to another. Epitope spreading? Scand J Immunol. 2018;87:e12657.
Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, van Riel P. L. C. M., Gabriel SE, Matteson EL, Kvien TK, Douglas K, Sandoo A, Arts E, Wållberg-Jonsson S, Innala L, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon C, Ramos VP, Yáñez IC, Sfikakis PP, Zampeli E, Gonzalez-Gay MA, Corrales A, van de Laar M, Vonkeman HE, Meek I, Semb AG on behalf of A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 2018;77:48-54
Zampeli Ε, Skopouli FN, Athanasakos A, Moutsopoulos HM. Rapidly progressive lung disease in a patient with signs of clinically amyopathic dermatomyositis. Clin Exp Rheumatol 2017;35:1057-1058
Manoussakis MN, Mavragani CP, Nezos A, Zampeli E , Germenis A, Moutsopoulos HM. Type I interferonopathy in a young adult. Rheumatology (Oxford) 2017;56:2241-2243
Zampeli E, Klinman DR, Gershwin EM and Moutsopoulos HM. A Comprehensive Evaluation for the Treatment of Lupus Nephritis. J Autoimmun. 2017;78:1-10.
Zampeli E, Moutsopoulos HM. Livedoid vasculopathy. Arthritis Rheumatol 2017;69:2096
Crowson CS, Gabriel SE, Semb AG, van Riel PLCM, Karpouzas G, Dessein PH, Hitchon C, Pascual-Ramos V, Kitas GD; Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatology (Oxford). 2017;56:1102-1110
Zampeli E, Moutsopoulos HM. IgG4-Related Orbital Disease Presenting With Unilateral Eyelid Swelling. Arthritis Rheumatol. 2016;11:2824.
Plastiras SC, Zampeli E, Moutsopoulos HM. Chest pain in a 39 year old man: what could be the underlying cause? Am J Med. 2016;12:e329-e330.
Zampeli E, Fragoulis GE, Moutsopoulos HM. IgG4-related sialadenitis and Sjögren's syndrome. Oral Dis. 2016;26:152-156.
Protogerou AD, Fransen J, Zampeli E, Argyris AA, Aissopou E, Arida A, Konstantonis GD, Tentolouris N, Makrilakis K, Psichogiou M, Daikos G, Kitas GD, Sfikakis PP. The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. PLoS One. 2015;10:e0132307.
Arida A, Zampeli E, Konstantonis G, Fragiadaki K, Kitas GD, Protogerou AD, Sfikakis PP. Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors. Clin Rheumatol. 2015;34:853-9.
Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG. Treatment of rheumatoid arthritis: Unraveling the conundrum. J Autoimmun. 2015;65:1-18.
Kyriakidis K, Zampeli E, Palaiologou M, Tiniakos D, Tiligada E. Histamine H3 and H4 receptor ligands modify vascular histamine levels in normal and arthritic large blood vessels in vivo. Inflammation 2015;38:949-958.
Zampeli E, Raftakis I, Michelongona A, Nikolaou C, Elezoglou A, Toutouzas K, Siores E, Sfikakis PP. Detection of subclinical synovial inflammation by microwave radiometry. PLoS One. 2013;8:e64606.
Bamias G, Stamatelopoulos K, Zampeli E, Protogerou A, Sigala F, Papamichael C, Christopoulos P, Kitas GD, Sfikakis PP. Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis. Clin Immunol. 2013;147:144-50.
Toutouzas K, Sfikakis PP, Karanasos A, Aggeli C, Felekos I, Kitas G, Zampeli E, Protogerou A, Stefanadis C. Myocardial ischaemia without obstructive coronary artery disease in rheumatoid arthritis: hypothesis-generating insights from a cross-sectional study. Rheumatology (Oxford). 2013;52:76-80.
Protogerou AD, Panagiotakos DB, Zampeli E, Argyris AA, Arida K, Konstantonis GD, Pitsavos C, Kitas GD, Sfikakis PP. Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white coat" phenomenon. Arthritis Res Ther. 2013;15:R142.
Protogerou A, Zampeli E, Tentolouris N, Makrilakis K, Kitas G, Sfikakis PP. Subclinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a case- control study. Ann Rheum Dis. 2012;71:1534-6.
Zampeli E, Protogerou A, Stamatelopoulos K, Fragiadaki K, Katsiari CG, Kyrkou K, Papamichael CM, Mavrikakis M, Nightingale P, Kitas GD, Sfikakis PP. Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther. 2012;14:R44.
Protogerou AD, Zampeli E, Sfikakis PP. Low-dose prednisone inclusion in a methotrexate- based, tight control strategy for early rheumatoid arthritis. Ann Intern Med. 2012;157:299-300
Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfikakis PP. A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis. 2011;219:734-6.
Papathanassiou M, Giannoulaki V, Zampeli E, Tiligada E. Effect of aminoguanidine on the conjunctival histamine and nitric oxide levels in experimental conjunctivitis J Ocular Pharmacol Ther 2011;27:137-142.
Papathanassiou M, Zampeli E, Mehta JS, Theodossiadis P. Unusual case of silent corneal perforation in a human immunodeficiency virus-infected patient. Clin Exp Optom. 2011;94:589-91.
Papathanassiou M, Zampeli E, Kaplanoglou T, Theodossiadis P. Peripheral ulcerative keratitis in a patient with systemic-onset juvenile idiopathic arthritis. J Pediatr Ophthalmol Strabismus. 2010;47 Online:e1-3.
Stamatelopoulos KS, Kitas GD, Papamichael CM, Kyrkou K, Zampeli E, Fragiadaki K, Panoulas VF, Mavrikakis M, Sfikakis PP. Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis. 2010;212:305-9.
Zampeli E, Thurmond RL, Tiligada E. The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva. Inflamm Res 2009;58:285-291.
Tiligada E, Zampeli E, Sander K, Stark H. Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 2009;18:1519-1531.
Zampeli E, Pitychoutis P, Papadopoulou-Daifoti Z, Tiligada E. Systemic challenge with lipopolysaccharide increases histamine levels in the conjunctiva and cartilage, but not hypothalamus of Sprague Dawley rats. Inflamm Res 2009;58(S1):S49-50.
Zampeli E, Tiligada E. The role of H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009;157:24-33.
Kyriakidis K, Zampeli E, Tiligada E. Histamine levels in whole peripheral blood from women with ductal breast cancer: A pilot study. Inflamm Res 2009;58(S1):S73-74.
Papathanassiou M, Petrou P, Zampeli E, Vergados I, Paikos P. Disseminated hydatid disease in a child: albendazole treatment of orbital cyst. Eur J Ophthalmol. 2008;18:1034-6.
Kakavas S, Zampeli E, Papamichael K, Delitheos B, Tiligada E. The mast cell pathway to inflammation and homeostasis: pharmacological insights. Anti-Inflamm Anti-Allergy Agents Med Chem 2006;5:323-334.
Ανακοινωσεις σε Διεθνη & Ελληνικα Συνεδρια
Venetsanopoulou A, Zampeli E, Christaki S, Argyropoulou O, Boki KA, Manoussakis MN, Skopouli FN, Tzioufas A, Moutsopoulos HM. Clinical features, treatment modalities and relapse rates in Geek patients with retroperitoneal fibrosis. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2019
Argyropoulou O, Goules A, Zampeli E, Mavromati M, Mavragani C, Skopouli FN, Moutsopoulos HM, Tzioufas A. Analysis of clinical and serological picture of patients with primary Sjögren’s syndrome and an early disease onset at age before 35 years. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2019
Flessa CM, Nezos A, Zampeli E, Moutsopoulos HM, Mavragani C. Association between single nucleotide polymorphisms (snps) of the baff gene and fatigue in primary Sjögren’s syndrome. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2019
Pezoulas V, Exarchos T, Venetsanopoulou A, Zampeli E, Gandolfo S, De Vita S, Skopouli FN, Tzioufas AG, Fotiadis D. Enhancing the quality of clinical data through data curation in primary sjögren’s syndrome. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2019
Crowson CS, Gabriel SE, Semb AG, van Riel PL, Karpouzas G, Dessein PH, Hitchon C, Pascual Ramos V, Kitas GD, on behalf of A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Rheumatoid arthritis-specific cardiovascular risk calculators are not superior to risk calculators established for the general population: a validation analysis in a cohort of ra patients from 7 countries. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2016
Protogerou AD, Konstantonis G, Aisopou E, Arida A, Zampeli E, Kitas GD, Sfikakis PP. Central aortic systolic blood pressure measurements in rheumatoid arthritis: towards the optimization of the blood pressure-associated cardiovascular risk assessment. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2015
A. Arida, E. Zampeli, G. Konstantonis, K. Fragkiadaki, G. D. Kitas, A. D. Protogerou, P. P. Sfikakis. Accelerated subclinical atheromatosis, but not arterial stiffness or hypertrophy, in rheumatoid arthritis patients free of classical risk factors. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2014
A. Protogerou, E. Zampeli, G. D. Konstantonis, K. Arida, DB. Panagiotakos, A. A. Argyris, C. Pitsavos, GD. Kitas, PP. Sfikakis. Arterial hypertension in rheumatoid arthritis without cardiovascular disease: high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2013.
E. Zampeli, I. Raftakis, A. Michelongona, C. Nikolaou, A. Elezoglou, C. Antoniadis, K. Toutouzas, P.P. Sfikakis. Measurement of joint temperature by microwave radiometry as a novel and simple method for the detection of synovial inflammation: a pilot study. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2012.
A. Protogerou, E. Zampeli, N. Tentolouris, K. Makrilakis, G.D. Kitas, P.P. Sfikakis. Subclinical atherosclerosis in the femoral arteries: similar prevalence in rheumatoid arthritis and diabetes mellitus in a case control study. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2012
E. Zampeli, A. Protogerou, K. Stamatelopoulos, K. Fragiadaki, CG. Katsiari, K. Kyrkou, CM. Papamichael, M. Mavrikakis, P. Nightingale, PP. Sfikakis. Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Excellence in Rheumatology 2012
E. Zampeli, A. Karanasos, I. Felekos, C. Aggeli, C. Stefanadis, K. Toutouzas, A. Protogerou, PP. Sfikakis. Silent myocardial ischemia without angiographically significant coronary artery disease in rheumatoid arthritis versus diabetes Excellence in Rheumatology 2012
Makris MP, Lethbridge NL, Zampeli E, Aggelides XS, Chazot PL, Tiligada E. Blood histamine levels and skin H4R expression in patients with chronic spontaneous urticaria. EHRS 2012
E. Zampeli, K. Fragiadaki, A. Protogerou, K. Stamatelopoulos, S. Panopoulos, C. Papamichael, P.P. Sfikakis. Treatment with tocilizumab improves arterial function in rheumatoid arthritis: a 6-month pilot study. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2011
P.P. Sfikakis, G. Bamias, E. Zampeli, A.D. Protogerou, C. Papamichael, K. Stamatelopoulos. Baseline serum levels of TNF-like cytokine 1a (TL1a) and its decoy receptor 3 (DCR3) predict formation of new atherosclerotic plaques during the next 3.5 years in patients with rheumatoid arthritis. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2011
E. Zampeli, A. Protogerou, K. Stamatelopoulos, K. Fragiadaki, C. Katsiari, K. Kyrkou, C. Papamichael, M. Mavrikakis, G. D Kitas and P. P Sfikakis. Rate of Progression of Subclinical Atherosclerosis in Femoral Versus Carotid Arteries in Patients with Rheumatoid Arthritis Over 3 Years. ACR 2011
A. Karanasos, I. Felekos, C. Aggeli, E. Zampeli, A. Protogerou, C. Stefanadis, G. Kitas, K. Toutouzas, PP Sfikakis. Myocardial Ischemia in Asymptomatic Patients with Rheumatoid Arthritis: A Comparative Study with Diabetes Mellitus. ACR 2011
E. Zampeli, A. Protogerou, K. Stamatelopoulos, K. Fragiadaki, C. Katsiari, K. Kyrkou, C. Papamichael, M. Mavrikakis, G. D. Kittas, PP. Sfikakis. Formation of new atherosclerotic plaques in well-controlled rheumatoid arthritis depends on classical cardiovascular risk factors: a prospective longitudinal study. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2011
Chalkiadakis S, Zampeli E, Tiligada E. Histamine H4 receptors mediate systemic effects in the rat conjunctiva. ARVO Annual Meeting 2011
Kyriakidis K, Zampeli E, Tiligada E. Effects of the H3 and H4 receptor inverse agonists on the histamine levels of peripheral blood vessels in rats with adjuvant arthritis, 2nd Annual Meeting of the Balkan Venous Forum, 2011
Kyriakidis K, Zampeli E, Papamichael K, Tiligada E. Effects of the H3 receptor inverse agonist GSK334429 on the histamine levels of cartilage, oesophagus and peripheral blood vessels in rats with adjuvant arthritis. Proceedings of the Annual Meeting of the EHRS, 2010
Stamatelopoulos KS, Kitas GD, Papamichael C, Kyrkou K, Zampeli E, Fragiadaki K, Panoulas VF, Mavrikakis M, Sfikakis PP. Peripheral arterial disease in rheumatoid arthritis. Πανευρωπαϊκό Συνέδριο Ρευματολογίας EULAR 2010
Kyriakidis K, Zampeli E, Tiligada E. Effect of the H4 receptor antagonist JNJ7777120 on histamine levels of peripheral blood vessels in rats with adjuvant arthritis. EHRS, 2009
Zampeli E, Kyriakidis K, Tiligada E. Differential effects of H1 and H4 receptor antagonists on the cartilage histamine content in rats with adjuvant arthritis. EHRS, 2009
Zampeli E, Thurmond Rl, Tiligada E. Effect of the H4R antagonist JNJ7777120 on the cartilage histamine content in rats with adjuvant arthritis. EPHAR 2008
Kyriakidis K, Zampeli E, Tiligada E. Α pilot study on peripheral blood histamine levels in women with ductal breast cancer. EHRS, 2008
Zampeli E, Pitychoutis P, Papadopoulou-Daifoti Z, Tiligada E. Systemic challenge with lipopolysaccharide induces histamine levels in the rat conjunctiva and cartilage but not in the hypothalamus. EHRS, 2008
Papamichael K, Zampeli E, Mantzaris G, Tiligada E. Blood histamine levels in patients with inflammatory bowel disease on infliximab therapy: Preliminary results. EHRS, 2008
Kyriakidis DA, Theodorou MC, Filippou PS, Panagiotidis CA, Kyriakidis KD, Zampeli E, Tiligada E. Modulation of E. coli AtoS-AtoC two component system by biogenic amines. International Congress on Biogenic Amines ‘Biological and Clinical Perspectives’, 2007
Zampeli E, Kakavas S, Kyriakidis K, Tiligada E. Histamine levels in the conjunctiva, costosternal cartilage and brain of normal and cromolyn-treated rats. International Congress on Biogenic Amines ‘Biological and Clinical Perspectives’, 2007
Zampeli E, Thurmond RL, Tiligada E. Effect of the H4R antagonist JNJ7777120 on the histamine content in the rat conjunctiva: a preliminary in vivo study. EHRS, 2007
Kakavas S, Zampeli E, Delitheos V, Tiligada E. Tissue-related immune-endocrine interactions in experimental hyperthyroidism. EHRS, 2006
Ζαμπέλη Ε, Καλογήρου Ε-Μ., Πιπέρη Ε., Μαυραγάνη Κ.Π., Σκλαβούνου Α., Μουτσόπουλος Χ.Μ. (Υψηλός δείκτης ξηρότητας του στοματικού βλεννογόνου: ένας επιπρόσθετος δυσμενής προγνωστικός παράγοντας ανάπτυξης λεμφώματος σε ασθενείς με σύνδρομο Sjögren. Πανελλήνιο Συνέδριο Ρευματολογίας, 2016
Α. Καρανάσος, Κ. Τούτουζας, Κ. Αγγέλη, Ι. Φελέκος, Ε. Τσιάμης, Π. Σφηκάκης, Γ. Κίτας, Ε. Ζαμπέλη, Χ. Στεφανάδης. Η ρευματοειδής αρθρίτιδα συσχετίζεται με ισχαιμία μυοκαρδίου, παρόμοια με αυτή στο σακχαρώδη διαβήτη, αλλά απουσία αποφρακτικής στεφανιαίας νόσου. 33ο Πανελλήνιο Συνέδριο Καρδιολογίας, 2012
Ε. Ζαμπέλη, Α. Πρωτογέρου, Κ. Σταματελόπουλος, Κ. Φραγκιαδάκη, Χ. Κατσιάρη, Α. Κύρκου, Χ. Παπαμιχαήλ , M. Μαυρικάκης, Π. Π. Σφηκάκης. Παράγοντες που προβλέπουν την εμφάνιση νέων αθηρωματικών πλακών στη ρευματοειδή αρθρίτιδα: μακροχρόνια προοπτική μελέτη σε 64 ασθενείς. Πανελλήνιο Συνέδριο Ρευματολογίας, 2010
Ε. Ζαμπέλη, Κ. Σταματελόπουλος, Α. Πρωτογέρου, Κ. Φραγκιαδάκη, Χ. Κατσιάρη, Αικ. Κύρκου, Χ. Παπαμιχαήλ, M. Μαυρικάκης, Π. Π. Σφηκάκης (2010). Η εξέλιξη της αθηρωμάτωσης σε ασθενείς με ρευματοειδή αρθρίτιδα και αντίστοιχους μάρτυρες: προοπτική, μακροχρόνια μελέτη. Πανελλήνιο Συνέδριο Ρευματολογίας, 2010
Κ. Φραγκιαδάκη, Ε. Ζαμπέλη, Α. Πρωτογέρου, Κ. Σταματελόπουλος, Χ. Παπαμιχαήλ, Π. Π. Σφηκάκης (2010). Η αγωγή με τοσιλιζουμάμπη αναστρέφει την ενδοθηλιακή δυσλειτουργία σε ασθενείς με ρευματοειδή αρθρίτιδα: πιλοτική μελέτη 6 μηνών. Πανελλήνιο Συνέδριο Ρευματολογίας, 2010
Ζαμπέλη Ε, Thurmond Rl, Τυλιγάδα A (2008) Δράση του Η4 ισταμινεργικού υποδοχέα στο χόνδρο επιμύων με πειραματική αρθρίτιδα. Πανελλήνιο Συνέδριο Ρευματολογίας, 2008
Ομιλιες σε συνεδρια - ημεριδες ως προσκεκλημενη ομιλητρια
2023: 28ο Κοινό Συνέδριο Ελληνικής Εταιρείας Χειρουργικής Χεριού & Ελληνικής Εταιρείας Επανορθωτικής Μικροχειρουργικής, "Rheumatoid hand. Evaluation, non-surgical treatment and limits"
2021: Web Scientific Event: Ανοσοθεραπεία-Νεότερες Εξελίξεις, «Ανοσοθεραπεία και τοξικότητα. Την αντιμετωπίζουμε σωστά; - Ο ρόλος του ρευματολόγου»
2021: Πανελλήνιο Ακτινολογικό Συνέδριο, «Σπονδυλοαρθροπάθειες- ιερολαγονίτιδες: από το Α στο Ω. Άποψη κλινικού -κλινική εξέταση, διερεύνηση».
2021: 29ο Έτος Ημέρες Παθολογίας 2021-Διλήμματα στην Κλινική Παθολογία, «Ρευματοειδής Αρθρίτιδα καθυστερημένης έναρξης (late onset)»
2019: Hands On Skills Course “Multidisciplinary Care in Thoracic Oncology”, European Respiratory Society (ERS), “Immunotherapy in high risk population”.
2018: 12ο Συνέδριο Ογκολογίας στην Πρωτοβάθμια Περίθαλψη με θέμα: Νεότερα δεδομένα στη διαχείριση και αντιμετώπιση ασθενών με νεοπλάσματα θώρακος. «Ανοσοθεραπεία: ρευματολογικές εκδηλώσεις»
2018: 1st International Masterclass on immune-mediated adverse events, Συμμετοχή ως Εκπαιδευτής με θέμα «Rheumatic & musculoskeletal immune-related adverse events in patients on immune checkpoint inhibitors»
2018: 27ο Έτος Ημέρες Παθολογίας 2018, Κλινικό φροντιστήριο, «Αρθραλγία και αρθρίτιδα: δύο έννοιες που πρέπει να διαφοροποιεί από την αρχή ο κλινικός γιατρός»
2018: 10ο Ετήσιο Πανελλήνιο Συνέδριο ΕΠΕΜΥ «Νέα ένδειξη του Tocilizumab: Παρουσίαση περιστατικών με γιγαντοκυτταρική αγγειίτιδα»
